345 related articles for article (PubMed ID: 17042669)
1. Iliac anastomotic stenting with a sirolimus-eluting biodegradable poly-L-lactide stent: a preliminary study after 6 weeks.
Bünger CM; Grabow N; Kröger C; Lorenzen B; Hauenstein K; Goosmann M; Schmitz KP; Kreutzer HJ; Lootz D; Ince H; Nienaber CA; Klar E; Schareck W; Sternberg K
J Endovasc Ther; 2006 Oct; 13(5):630-9. PubMed ID: 17042669
[TBL] [Abstract][Full Text] [Related]
2. A biodegradable stent based on poly(L-lactide) and poly(4-hydroxybutyrate) for peripheral vascular application: preliminary experience in the pig.
Bünger CM; Grabow N; Sternberg K; Goosmann M; Schmitz KP; Kreutzer HJ; Ince H; Kische S; Nienaber CA; Martin DP; Williams SF; Klar E; Schareck W
J Endovasc Ther; 2007 Oct; 14(5):725-33. PubMed ID: 17924740
[TBL] [Abstract][Full Text] [Related]
3. Iliac anastomotic stenting with a biodegradable poly-L-lactide stent: a preliminary study after 1 and 6 weeks.
Bünger CM; Grabow N; Sternberg K; Ketner L; Kröger C; Lorenzen B; Hauenstein K; Schmitz KP; Kreutzer HJ; Lootz D; Ince H; Nienaber CA; Klar E; Schareck W
J Endovasc Ther; 2006 Aug; 13(4):539-48. PubMed ID: 16928171
[TBL] [Abstract][Full Text] [Related]
4. Sirolimus-eluting biodegradable poly-L-lactide stent for peripheral vascular application: a preliminary study in porcine carotid arteries.
Bünger CM; Grabow N; Sternberg K; Kröger C; Ketner L; Schmitz KP; Kreutzer HJ; Ince H; Nienaber CA; Klar E; Schareck W
J Surg Res; 2007 May; 139(1):77-82. PubMed ID: 17292417
[TBL] [Abstract][Full Text] [Related]
5. Drug-eluting biodegradable poly-D/L-lactic acid vascular stents: an experimental pilot study.
Uurto I; Mikkonen J; Parkkinen J; Keski-Nisula L; Nevalainen T; Kellomäki M; Törmälä P; Salenius JP
J Endovasc Ther; 2005 Jun; 12(3):371-9. PubMed ID: 15943514
[TBL] [Abstract][Full Text] [Related]
6. Vascular Response Toward an Absorbable Sirolimus-eluting Polymeric Scaffold for Vascular Application in a Model of Normal Porcine Carotid Arteries.
Kischkel S; Bünger CM; Grabow N; Erdle B; Kabelitz M; Moreth F; Martin DP; Williams SF; Reske T; Schmitz KP; Schareck W; Püschel A
Ann Vasc Surg; 2022 Feb; 79():324-334. PubMed ID: 34648854
[TBL] [Abstract][Full Text] [Related]
7. The effect of an intraluminal stent on neointimal hyperplasia at an end-to-side polytetrafluoroethylene graft arterial anastomosis.
Chalmers RT; Hoballah JJ; Sharp WJ; Kresowik TF; Corson JD
Am J Surg; 1994 Aug; 168(2):85-90. PubMed ID: 7519832
[TBL] [Abstract][Full Text] [Related]
8. Anastomotic stenting in a porcine aortoiliac graft model.
Bünger CM; Grabow N; Hauenstein K; Ketner L; Kröger C; Sternberg K; Kramer S; Lootz D; Schmitz KH; Kreutzer HJ; Klar E; Schareck W
Lab Anim; 2007 Jan; 41(1):71-9. PubMed ID: 17234052
[TBL] [Abstract][Full Text] [Related]
9. A novel biodegradable stent applicable for use in congenital heart disease: bench testing and feasibility results in a rabbit model.
Veeram Reddy SR; Welch TR; Wang J; Bernstein F; Richardson JA; Forbess JM; Nugent AW
Catheter Cardiovasc Interv; 2014 Feb; 83(3):448-56. PubMed ID: 23592519
[TBL] [Abstract][Full Text] [Related]
10. Oral everolimus inhibits in-stent neointimal growth.
Farb A; John M; Acampado E; Kolodgie FD; Prescott MF; Virmani R
Circulation; 2002 Oct; 106(18):2379-84. PubMed ID: 12403670
[TBL] [Abstract][Full Text] [Related]
11. Rapamycin-coated expanded polytetrafluoroethylene bypass grafts exhibit decreased anastomotic neointimal hyperplasia in a porcine model.
Cagiannos C; Abul-Khoudoud OR; DeRijk W; Shell DH; Jennings LK; Tolley EA; Handorf CR; Fabian TC
J Vasc Surg; 2005 Nov; 42(5):980-8. PubMed ID: 16275457
[TBL] [Abstract][Full Text] [Related]
12. Development of a sirolimus-eluting poly (L-lactide)/poly(4-hydroxybutyrate) absorbable stent for peripheral vascular intervention.
Grabow N; Bünger CM; Kischkel S; Timmermann JH; Reske T; Martin DP; Williams SF; Schareck W; Sternberg K; Schmitz KP
Biomed Tech (Berl); 2013 Oct; 58(5):429-37. PubMed ID: 23898020
[TBL] [Abstract][Full Text] [Related]
13. Antirestenotic effects of a novel polymer-coated d-24851 eluting stent. Experimental data in a rabbit iliac artery model.
Lysitsas DN; Katsouras CS; Papakostas JC; Toumpoulis IK; Angelidis C; Bozidis P; Thomas CG; Seferiadis K; Psychoyios N; Frillingos S; Pavlidis N; Marinos E; Khaldi L; Sideris DA; Michalis LK
Cardiovasc Intervent Radiol; 2007; 30(6):1192-200. PubMed ID: 17828426
[TBL] [Abstract][Full Text] [Related]
14. Vascular response and mechanical integrity of the new biodegradable polymer coated sirolimus-eluting PROLIM stent implanted in porcine coronary arteries.
Milewski K; Gorycki B; Buszman PP; Jelonek M; Beaudry D; Lapointe JM; Guy LG; Abusamra M; Pająk J; Kinasz W; Wojakowski W; Leclerc G; Gil RJ; Buszman PE
Kardiol Pol; 2012; 70(7):703-11. PubMed ID: 22825946
[TBL] [Abstract][Full Text] [Related]
15. Arsenic trioxide eluting stent reduces neointima formation in a rabbit iliac artery injury model.
Yang W; Ge J; Liu H; Zhao K; Liu X; Qu X; Li W; Huang Y; Sun A; Zou Y
Cardiovasc Res; 2006 Dec; 72(3):483-93. PubMed ID: 17020754
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance evaluation of luminal patency after polylactide stent implantation: an experimental study in a rabbit aorta model.
Hietala EM; Maasilta P; Ståhls A; Salminen US; Harjula AL; Välimaa T; Kivisaari L
Eur Radiol; 2003 May; 13(5):1025-32. PubMed ID: 12695824
[TBL] [Abstract][Full Text] [Related]
17. Comparison of early vascular morphological changes between bioresorbable poly-L-lactic acid scaffolds and metallic stents in porcine iliac arteries.
Sekimoto Y; Obara H; Matsubara K; Fujimura N; Harada H; Kitagawa Y
Organogenesis; 2017 Apr; 13(2):29-38. PubMed ID: 28102777
[TBL] [Abstract][Full Text] [Related]
18. Experimental efficacy of an everolimus eluting cobalt chromium stent.
Carter AJ; Brodeur A; Collingwood R; Ross S; Gibson L; Wang CA; Haller S; Coleman L; Virmani R
Catheter Cardiovasc Interv; 2006 Jul; 68(1):97-103. PubMed ID: 16755598
[TBL] [Abstract][Full Text] [Related]
19. Sirolimus-eluting stents in the canine cerebral vasculature: a prospective, randomized, blinded assessment of safety and vessel response.
Levy EI; Hanel RA; Howington JU; Nemes B; Boulos AS; Tio FO; Paciorek AM; Amlani S; Kagan-Hallett KS; Fronckowiak MD; Guterman LR; Hopkins LN
J Neurosurg; 2004 Apr; 100(4):688-94. PubMed ID: 15070124
[TBL] [Abstract][Full Text] [Related]
20. A novel bioengineered small-caliber vascular graft incorporating heparin and sirolimus: excellent 6-month patency.
Ishii Y; Sakamoto S; Kronengold RT; Virmani R; Rivera EA; Goldman SM; Prechtel EJ; Hill JG; Damiano RJ
J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1237-45; discussion 1245-6. PubMed ID: 18544361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
